anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

190,381-190,440 of 319,975

filter-aware
08
Includes clinical trial data from PERSIST-2 study.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
09
The slide outlines a randomized controlled trial design for Myelofibrosis treatment.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
10
The slide uses a process flow diagram to represent clinical trial methodology.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
11
Includes two charts: a bar chart for SVR achievement and a waterfall plot for median percentage change in spleen volume.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
12
Includes a bar chart for response rates and a waterfall plot for individual patient symptom changes.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
13
The slide uses three bar charts to illustrate clinical efficacy endpoints related to anemia in a specific patient population.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
14
Data presented as median values with interquartile ranges (IQR).CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
15
The slide presents data from a retrospective analysis of the PERSIST-2 trial.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
16
The slide uses a biological process diagram to explain the mechanism of action.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
17
The slide compares two different clinical trial datasets (PERSIST-2 vs MOMENTUM) to highlight efficacy.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
18
CTI BioPharma | Investor Presentation Deck | 24 slidesCTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Go-to-MarketLoop · Quick Win Big Bet1 hit
19
Slide emphasizes clinical validation and market positioning via guideline inclusion.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Go-to-MarketLoop · Quick Win Big Bet1 hit
20
CTI BioPharma | Investor Presentation Deck | 24 slidesCTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Go-to-MarketLoop · Quick Win Big Bet1 hit
21
The slide uses a three-column layout to summarize key product benefits.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
22
The slide highlights financial stability to support commercialization efforts.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
23
The slide uses a three-column layout to summarize key business pillars.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
24
CTI BioPharma | Investor Presentation Deck | 24 slidesCTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
01
Slide 1
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Attention1 hit
02
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Attention1 hit
03
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a background image of headphones to reinforce the 'music' theme of the strategy.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Attention1 hit
05
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Attention1 hit
06
The slide features a person holding a smartphone displaying a circular 'flow' interface.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Interest1 hit
07
The slide uses a hub-and-spoke visual layout with the Deezer logo at the center.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Interest1 hit
08
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Interest1 hit
09
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Interest1 hit
10
The slide uses stacked bar charts to show revenue composition and YoY growth percentages, including FX-adjusted figures.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · DesireLoop · So What Cascade1 hit
11
The chart uses a stacked bar format with annotations for YoY changes and percentage of revenue.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · DesireLoop · So What Cascade1 hit
12
The chart uses a standard waterfall bridge to explain the variance in EBITDA between two periods.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
13
The chart uses a waterfall bridge to explain the movement of cash over a 12-month period.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
14
Slide number 14, section number 03.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Action1 hit
15
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Action1 hit
16
The slide uses a stylized background image of a building with illuminated windows.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Action1 hit
17
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations 1 hit
18
The slide uses a split-bar chart approach to compare metrics across two time periods for two business segments.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations 1 hit
19
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations 1 hit
20
The slide presents three distinct reconciliation blocks: Gross Profit to Adjusted Gross Profit, Operating Loss to Adjusted EBITDA, and Cash Flow to Free Cash Flow.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations 1 hit
21
Financial data presented in K€.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations 1 hit
22
The table displays financial data in thousands of Euros (K€).Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations 1 hit
23
The table displays financial figures in K€.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations 1 hit
24
The slide presents financial data in K€.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations 1 hit
25
Part 2 of a 2-part cash flow statement.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations 1 hit
01
Slide 1
Exhibit 99.1 indicates this is likely a regulatory or investor relations filing.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations 1 hit
02
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations 1 hit
03
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations 1 hit
04
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations 1 hit
05
The slide uses a list-based layout to present key metrics with corresponding descriptions.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · KPI Overview1 hit
06
The slide includes the KDIGO 2012 CKD prognosis matrix.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations 1 hit
07
The slide uses a process-oriented diagram to visualize clinical milestones.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations 1 hit
08
Data sourced from the Accelerating Medicines Partnership (AMP) Lupus Network.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · Key Takeaways1 hit
09
The slide uses stacked bar charts to compare response rates (Complete, Partial, No Response) at different time intervals for two drugs.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
11
Includes scientific citation at the bottom.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a 'Bench to Bedside' narrative structure to present scientific evidence.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
The slide uses a visual process flow to explain the mechanism of action.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
14
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide outlines a clinical trial structure with 5 cohorts ranging from 0.4 to 3.2 mg/kg.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Includes clinical trial abbreviations and source citation in footer.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide appears to be a template or placeholder with only the title present.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide compares clinical trial data for two different drugs using different metrics (fold change vs median % reduction).Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit